Moreover, we found that neutralizing IFN-β markedly promoted tumor growth and ascites formation (Fig. 7c) and shortened the survival of the mice (Fig. 7d), suggesting that IFN-β plays a critical role in mediating the antitumor effect of drug-MPs against malignant ascites. The gene discussed is IFNB1; the disease is cancer.